Genistein inhibits the proliferation of human multiple myeloma cells through suppression of nuclear factor‑κB and upregulation of microRNA‑29b

Xie,Jie; Wang,Jianchao; Zhu,Bo

doi:10.3892/mmr.2015.4740

Genistein inhibits the proliferation of human multiple myeloma cells through suppression of nuclear factor‑κB and upregulation of microRNA‑29b

Authors:
- Jie Xie
- Jianchao Wang
- Bo Zhu
View Affiliations

Affiliations: Department of Traumatic Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Orthopedic Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: December 30, 2015 https://doi.org/10.3892/mmr.2015.4740
Pages: 1627-1632

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple myeloma (MM) is a malignant tumor and is the most common primary tumor of the bone marrow in the USA. Genistein is predominantly found in Leguminosae and various lines of evidence have indicated that it suppresses cell growth, induces programmed cell death and inhibits angiogenesis. As a result of these capabilities, genistein presents as a promising cancer chemopreventive agent. However, the effect of genistein on MM remains to be elucidated. The present study investigated the effect of genistein on the proliferation and apoptosis of MM cells through the regulation of nuclear factor‑κB (NF‑κB) and microRNA‑29b (miR‑29b). In the present study, cell proliferation was examined using a 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay. In addition, apoptosis was detected using an Annexin V‑fluorescein isothiocyanate/propidium iodide apoptosis assay and caspase‑3 activation assay. The expression of NF‑κB and miR‑29b was analyzed using western blotting and reverse transcription quantitative polymerase chain reaction, respectively. Finally, miR‑29b and anti‑miR‑29b plasmids were transfected into U266 cells to determine the effect of genistein on MM. In the present study, the results demonstrated that genistein could significantly reduce cell proliferation, induce apoptosis and increase the activity of caspase‑3 in U266 cells. Furthermore, it was found that genistein could suppress the protein level of NF‑κB and promote the expression of miR‑29b in U266 cells. The results also indicated that miR‑29b could alter the expression of NF‑κB in U266 cells. These findings suggest that genistein inhibits the proliferation of human MM cells by upregulating miR‑29b resulting in suppression of NF‑κB.

View Figures

View References

1	Kelly T, Børset M, Abe E, Gaddy-Kurten D and Sanderson RD: Matrix metalloproteinases in multiple myeloma. Leuk Lymphoma. 37:273–281. 2000.PubMed/NCBI
2	Barillé S, Akhoundi C, Collette M, Mellerin MP, Rapp MJ, Harousseau JL, Bataille R and Amiot M: Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2 and induction of MMP-1 by myeloma cells. Blood. 90:1649–1655. 1997.
3	He X, Yang K, Chen P, Liu B, Zhang Y, Wang F, Guo Z, Liu X, Lou J and Chen H: Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: A meta-analysis and systematic review. Onco Targets Ther. 7:1593–1599. 2014. View Article : Google Scholar : PubMed/NCBI
4	Hameed A, Brady JJ, Dowling P, Clynes M and O'Gorman P: Bone disease in multiple myeloma: Pathophysiology and management. Cancer Growth Metastasis. 7:33–42. 2014. View Article : Google Scholar : PubMed/NCBI
5	Fuchs O: Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma. Cardiovasc Hematol Disord Drug Targets. 13:16–34. 2013. View Article : Google Scholar : PubMed/NCBI
6	Manni S, Brancalion A, Mandato E, Tubi LQ, Colpo A, Pizzi M, Cappellesso R, Zaffino F, Di Maggio SA, Cabrelle A, et al: Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells. PLoS One. 8:e752802013. View Article : Google Scholar
7	Gatt ME, Takada K, Mani M, Lerner M, Pick M, Hideshima T, Carrasco DE, Protopopov A, Ivanova E, Sangfelt O, et al: TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity. Br J Haematol. 162:210–220. 2013. View Article : Google Scholar : PubMed/NCBI
8	Ni H, Zhao W, Kong X, Li H and Ouyang J: NF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosis. PLoS One. 9:e958462014. View Article : Google Scholar : PubMed/NCBI
9	Zhou JJ, Zheng S, Sun LF and Zheng L: MicroRNA regulation network in colorectal cancer metastasis. World J Biol Chem. 5:301–307. 2014. View Article : Google Scholar : PubMed/NCBI
10	Luo X, Gu J, Zhu R, Feng M, Zhu X, Li Y and Fei J: Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine. BMC Syst Biol. 8:822014. View Article : Google Scholar : PubMed/NCBI
11	Jagannathan S, Vad N, Vallabhapurapu S, Vallabhapurapu S, Anderson KC and Driscoll JJ: MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the anti-myeloma benefit of bortezomib. Leukemia. 29:727–738. 2015. View Article : Google Scholar :
12	Zhang YK, Wang H, Leng Y, Li ZL, Yang YF, Xiao FJ, Li QF, Chen XQ and Wang LS: Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. Biochem Biophys Res Commun. 414:233–239. 2011. View Article : Google Scholar : PubMed/NCBI
13	Qian K, Gao AJ, Zhu MY, Shao HX, Jin WJ, Ye JQ and Qin AJ: Genistein inhibits the replication of avian leucosis virus subgroup J in DF-1 cells. Virus Res. 192:114–120. 2014. View Article : Google Scholar : PubMed/NCBI
14	Suzuki R, Kang Y, Li X, Roife D, Zhang R and Fleming JB: Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Anticancer Res. 34:4685–4692. 2014.PubMed/NCBI
15	Choi EJ, Jung JY and Kim GH: Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosis. Exp Ther Med. 8:454–458. 2014.PubMed/NCBI
16	Li J, Li J, Yue Y, Hu Y, Cheng W, Liu R, Pan X and Zhang P: Genistein suppresses tumor necrosis factor α-induced inflammation via modulating reactive oxygen species/Akt/nuclear factor κB and adenosine monophosphate-activated protein kinase signal pathways in human synoviocyte MH7A cells. Drug Des Devel Ther. 8:315–323. 2014. View Article : Google Scholar
17	Jamadar-Shroff V, Papich MG and Suter SE: Soy-derived isoflavones inhibit the growth of canine lymphoid cell lines. Clin Cancer Res. 15:1269–1276. 2009. View Article : Google Scholar : PubMed/NCBI
18	Chen HF, Li ZY, Tang JQ, Shen HS, Cui QY, Ren YY, Qin LM, Jin LJ, Zhu JJ, Wang J, et al: Clinical study of thalidomide combined with dexamethasone for the treatment of elderly patients with newly diagnosed multiple myeloma. Asian Pac J Cancer Prev. 13:4777–4781. 2012. View Article : Google Scholar : PubMed/NCBI
19	Nakamura H and Wang Y, Xue H, Romanish MT, Mager DL, Helgason CD and Wang Y: Genistein versus ICI 182, 780: An ally or enemy in metastatic progression of prostate cancer. Prostate. 73:1747–1760. 2013. View Article : Google Scholar : PubMed/NCBI
20	Xue JP, Wang G, Zhao ZB, Wang Q and Shi Y: Synergistic cytotoxic effect of genistein and doxorubicin on drug-resistant human breast cancer MCF-7/Adr cells. Oncol Rep. 32:1647–1653. 2014.PubMed/NCBI
21	Zhang GJ and Zhang Z: Effect of Bcl-2 on apoptosis and transcription factor NF-κB activation induced by adriamycin in bladder carcinoma BIU87 cells. Asian Pac J Cancer Prev. 14:2387–2391. 2013. View Article : Google Scholar
22	Li Z, Yang Z, Peng X, Li Y, Liu Q and Chen J: Nuclear factor-κB is involved in the protocadherin-10-mediated pro-apoptotic effect in multiple myeloma. Mol Med Rep. 10:832–838. 2014.PubMed/NCBI
23	Luo Y, Wang SX, Zhou ZQ, Wang Z, Zhang YG, Zhang Y and Zhao P: Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-κB) pathway. Tumour Biol. 35:11483–11488. 2014. View Article : Google Scholar : PubMed/NCBI
24	Chung MH, Kim DH, Na HK, Kim JH, Kim HN, Haegeman G and Surh YJ: Genistein inhibits phorbol ester-induced NF-κB transcriptional activity and COX-2 expression by blocking the phosphorylation of p65/Rel in human mammary epithelial cells. Mutat Res. 768:74–83. 2014. View Article : Google Scholar : PubMed/NCBI
25	Amodio N, Bellizzi D, Leotta M, Raimondi L, Biamonte L, D'Aquila P, Di Martino MT, Calimeri T, Rossi M, Lionetti M, et al: miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells. Cell Cycle. 12:3650–3662. 2013. View Article : Google Scholar : PubMed/NCBI
26	Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL and Dahiya R: Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells. Br J Cancer. 110:1645–1654. 2014. View Article : Google Scholar : PubMed/NCBI
27	Xia J, Cheng L, Mei C, Ma J, Shi Y, Zeng F and Wang Z and Wang Z: Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells. Curr Pharm Des. 20:5348–5353. 2014. View Article : Google Scholar : PubMed/NCBI